FDA Inspection 800781 — Carter BloodCare at Hulen
The FDA completed an inspection of Carter BloodCare at Hulen on September 27, 2012 in Fort Worth, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- September 27, 2012
- Fiscal Year
- 2012
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Fort Worth, TX (United States)